0 followers
Cedilla is developing novel small-molecule therapeutics directed to unrecognized allosteric binding sites, providing new ways to target key cancer drivers and treat life threatening diseases.
Industries
Headquarters
Stage
Employees
Links
View full screen
Alexandra Glucksmann
View all
4 members
9 members
2 members
Coherus BioSciences
5 followers
BioMarin Pharmaceutical
20 followers
Adaptive Biotechnologies
11 followers
Eikon Therapeutics
1 follower
Dragonfly Therapeutics
Discover companies